The PRISMAP Consortium comprises 23 partners including 9 major EU, national or regional infrastructures, 4 emerging infrastructures, as well as top-level research centres, hospitals, the European Joint Research Centre and one SME. The PRISMAP partners come from 13 different countries, namely Austria, Belgium, Denmark, France, Germany, Italy, Latvia, Norway, Portugal, Poland, Sweden, Switzerland and UK, under the coordination of CERN, the European Laboratory for Nuclear Research.
The PRISMAP Consortium brings together a set of key large European, national and regional production infrastructures, chosen specifically for their expertise in the production and dispatch of non-conventional radionuclides. Their integration in a joint network will allow to provide new radionuclides and reach new purity grades for medical research. The research centres and hospitals of PRISMAP all demonstrate key competences in translational research and are crucial to foster a new research era based on emerging medical radionuclides. Importantly, as the PRISMAP community grows and strengthens along the years, options are provided to include new translational research centres as well as emerging production facilities once operational.